-1,1147,1193,14046,14061,14111,14139
search Menu

Mental Health and Wellbeing studies

A mental health professional talking to someone

GLAD

This study will explore genetic and environmental factors associated with risk for depression and anxiety disorders in the UK, to understand these common disorders and help develop better treatments.

You can take part in this study if you are over the age of 16 and have experienced clinical anxiety and/or depression in your life.

If you choose to take part, please select ‘Berkshire Healthcare’ when you're asked where you heard about this study.

Visit the GLAD study website to find out how to take part (opens new browser tab)

Contact our research team to find out more quoting 'GLAD' study (opens a new browser tab)

Recruitment end date is 30 November 2024

PPiP2

A study that aims to establish the prevalence of pathogenic antibodies in patients with first episode psychosis.

You can take part in this study if you are aged 16-60 and have been experiencing at least one symptom of psychosis for at least two weeks but not longer than two years. 

Contact our research team to find out more quoting 'PPiP2' study (opens a new browser tab)

Recruitment end date is 30 November 2027

Feeling Safer

Feeling Safer is a new six-month programme designed to help people feel safer, happier, and getting back doing more of the things they want to be doing. It is an online programme (accessed via a computer, tablet or smart phone) that is guided by a staff member. The purpose of this research is to see whether Feeling Safer may be helpful for people. To do this, everyone who takes part will receive Feeling Safer. We then compare how people were feeling before Feeling Safer to how they felt afterwards. The research is for adults (16 years+) who feel very concerned that others are trying to harm them in some way, and are attending mental health services for a diagnosis of psychosis.

Contact our research team to find out more quoting 'Feeling Safer' study (opens a new browser tab)

Recruitment end date is 30 January 2026

Pharmacogenetics

This study is researching whether genetic testing is beneficial for people who take antipsychotic medications. Genetic testing could help to improve the way we adjust the dose of these medications and help to reduce side effects. You can take part in this research if you are aged 18 or over, taking an antipsychotic medication, and willing to have a blood test and complete some questionnaires.

Contact our research team to find out more quoting 'Pharmacogenetics' study (opens a new browser tab)

Recruitment end date: 30 November 2024

Virtual Reality Study

Phoenix Virtual Reality therapy is for people attending psychosis services, aged between 16 and 30 years old, who are feeling low in self-confidence. The Virtual Reality therapy is an easy to use, step-by-step programme that provides experiences to help build up positive self-beliefs.

Contact our research team to find out more quoting ‘Phoenix’ study (opens a new browser tab)

Recruitment end date is 30 June 2024

Prolonged Grief study

Prolonged Grief Disorder is a newly recognised mental health problem arising after a bereavement. This study is investigating the acceptability of a new cognitive therapy programme for PGD to bereaved adults. The study involves working through the therapy programme online via computer or smartphone app, with guidance from a therapist via secure messaging and telephone/video calls, for three months.

Contact our research team to find out morequoting ‘Prolonged Grief’ study (opens a new browser tab)

Recruitment end date is 31 May 2027

PATTERN

We are looking for patients (both male and female), aged 18 and above. In order to participate, you must have a diagnosis of a psychiatric disorder or psychological difficulty (such as depression, anxiety, or eating disorders).

You would be invited to a Berkshire Healthcare NHS site (Prospect Park Hospital or University of Reading) for a research visit. This would take approximately 45 minutes for the first visit and approximately 30 minutes for subsequent visits during which specific physical parameters would be measured by two non-invasive devices. You would also complete a short demographic questionnaire.

Physical contact will be kept to a minimum wherever possible. We will follow University of Oxford, Local NHS Trust, and National PHE guidelines with regards to symptom checking, social distancing measures and appropriate personal protective equipment (PPE).

Contact our research team to find out more quoting 'PATTERN' study (opens a new browser tab)

Recruitment end date is 31 October 2023 (study to reopen soon)

MOLGEN

This study aims to understand the genetic and non genetic risk factors for patients who have had a drug reaction to Clozapine. 

If you are under the care of one of our mental health teams and think you may be eligible to take part.

Contact our research team to find out more quoting 'MOLGEN' study (opens a new browser tab)

Recruitment currently paused for this study but please still contact if you are interested